Theme: Underlining the Hurdles Involved in Developing New Antibiotics

Antibiotics 2016

Renowned Speakers

Antibiotics 2016

After a successful conference of Antibiotics 2015, we are currently bringing forth “2nd World Congress and Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2016) slated on October 13-15, 2016 at Manchester, UK. Antibiotics 2016 aims to gather the most elegant societies and industries along with the renowned and honorable persons from top universities across the globe.

Antibiotics 2016 covers various aspects of Antibiotics, The Emergence of Antimicrobial resistance,  Different Types of Antibiotics, Applications of Antibiotics, Antibiotic Resistance: Opportunities and Challenges, Antibiotics for Various Diseases and Infections, Antibiotic Prophylaxis, Antibiotics: In Pregnancy and Lactation, Antibiotics in Different Industries, Modern Antibiotics: Emerging trends, Barriers and Opportunities, Drug Discovery and Novel Delivery Technologies, Antibiotics for Emerging and Re-emerging Diseases, Micro Organisms in Recent Drug Discovery, Clinical Trials of Antibiotics, Antibiotics and Mechanism, Antibiotic Regulatory Affairs and Antibiotics Market Analysis and Business Opportunities.

Track 1: Antibiotics

Antibiotics are a type of antimicrobials that are used in treatment and prevention of bacterial infections. They may kill or inhibit the growth of bacteria. Many antibiotics are also effective against protozoans and fungi; some are toxic to humans and animals also, even when given in therapeutic dosage. Antibiotics are not effective against viruses such as common cold or influenza, and may be harmful when taken inappropriately. Physicians must ensure the patient has a bacterial infection before prescribing antibiotics

Relevant Conferences:

3rd Global Microbiologists Annual Meeting, August 15-17, 2016 Portland, Oregon, USA; 4th Annual Conference on Applied Microbiology, September 19-21, 2016 Las Vegas, USA; Conference on Infectious Diseases and Diagnostic Microbiology, October 3-5, 2016 Vancouver, Canada; 7th World Congress on Applied Microbiology, November 10-12, 2016 Istanbul, Turkey; 6th Clinical Microbiology Conference, October 20-22, 2016 Rome, Italy; Antimicrobial Stewardship in Veterinary Medicine Conference, September 10-11, 2016 Gothenburg, Sweden; World Antimicrobial Congress, September 8-9, 2016 Washington, DC, USA; EPHA 7th Annual Conference on Antibiotics Resistance, Politics and Public Health, September 8, 2016 Brussels, Belgium; 4th Conference on Antibiotics in Animals, September  26-28, 2016 The Hague, Netherlands;  Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), Alliance for the Prudent Use of Antibiotics (APUA), Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA)

 Track 2: The Emergence of Antimicrobial Resistance

Antibiotic resistance invoke especially to the resistance to antibiotics that occurs in common bacteria that cause infection. The easy approach and capability of Antibiotics led to overuse in live-stock raising promotes bacteria to flourish resistance. This led to comprehensive problems with antibiotic resistance. World Health Organization (WHO) classified antimicrobial resistance as a serious hazard and no longer a indicator for the future.  Antibiotic resistance is now among every part of the world and its stirring everyone irrespective to the age. When infections become resistant to first-line drugs, more costly therapies must be used. A longer duration of illness and treatment, often in hospitals, increases health care costs as well as the financial burden on families and societies. To help prevent the development of current and future bacterial resistance, it is essential to prescribe antibiotics according to the principles of antimicrobial stewardship, such as specify antibiotics only when they are needed.    

Relevant Conferences:

2nd Conference on Antimicrobial Agents and Chemotherapy, December 08-09, 2016 San Antonio, USA; 6th  Clinical Microbiology Conference, October 20-22, 2016 Rome, Italy; 5th Conference on Microbial Physiology and Genomics, September 29-30, 2016 London, UK; 7th World Congress on Applied Microbiology, November 10-12, 2016 Istanbul, Turkey; World Antimicrobial Congress, September 8-9, 2016 Washington, DC, USA; EPHA 7th  Annual Conference on Antibiotic Resistance, Politics and Public Health, September 8, 2016 Brussels, Belgium; 4th Conference on responsible use of antibiotics in animals, September 26-28, 2016 The Hague, Netherlands; Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance), ReActAction on Antibiotics, Transatlantic task force on urgent antimicrobial resistance (TATFAR), Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM)

Track 3: Antibiotic Resistance: Opportunities and Challenges

Certain bacterial infections now oppose all antibiotics. The resistance problem may be reversible, but only if society begins to acknowledge how the drugs affect "good" bacteria as well as "bad". Historically, most antibacterials were used in hospitals, where they were integrated into surgical clothes and soaps to limit the spread of infection. More recently, however, those substances (including  triclosan, triclocarbon and such quaternary ammonium compounds as benzalkonium chloride) have been mixed into lotions, dish-washing detergents and soaps meant for general consumers. They have also been impregnated into such items as cutting boards, toys, high chairs and mattress pads.   

Relevant Conferences:

7th World Conference on Applied Microbiology, November 10-12, 2016 Istanbul, Turkey; Conference on Infectious Diseases and Diagnostic Microbiology, October 3-5, 2016 Vancouver, Canada; 6th Clinical Microbiology Conference, October 20-22, 2016 Rome, Italy; 2nd World Congress on Infectious Diseases, August 24 - 26, 2016 Philadelphia, Pennsylvania, USA; EPHA 7th Annual Conference on Antibiotic Resistance and Public Health, September 8, 2016 Brussels, Belgium; 4th Conference on Responsible use of Antibiotics in animals, September 26-28, 2016 The Hague, Netherlands;  Conference on Antimicrobial Resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016; Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM), The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), Alliance for the Prudent Use of Antibiotics (APUA)

Track 4: Different Types of Antibiotics

Antibiotics are also noted as antibacterials, are types of medications that destroy or slow down the growth of bacteria. Alexander Fleming discovered first penicillin, the first chemical compound with antibiotic properties. Some of the common antibiotics are Aminoglycosides, Cephalosporins, Carbapenems, Macrolides, Penicillin, Quinolones, Sulfonamides and, Tetracyclines etc. General fundamentals of antibiotic prescribing are use: First-line antibiotics first, Reserve broad spectrum antibiotics for marked circumstances only, prescribe antibiotics for bacterial infections if Symptoms are significant or severe.

Relevant Conferences:

6th Global Summit on Toxicology and Applied Pharmacology, October 17-19, 2016 Houston, Texas, USA; 3rd World Congress on Pharmacology, August 08-10, 2016 Birmingham, UK; 10th Conference on Pharmaceutics and Novel Drug Delivery Systems, March 13-15, 2017 London, UK; 4th Conference on Clinical Pharmacy, November 07-09, 2016 Las Vegas, Nevada, USA; 4th conference on Antibiotics in Animals, September 26-28, 2016 The Hague, Netherlands; Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference on Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; American Public Health Association, American Nurses Association, Natural Resources Defense Council (NRDC), Keep Antibiotics Working (KAW), Institute for Agriculture and Trade Policy (IATP), Healthy Food Action

Track 5: Applications of Antibiotics

Choice of relevant antibiotics is presently based on individual patient need.  Preservation of bacterial sensitivity needs perceptive of how antibiotics select resistance. ‘Ten commandments’ which might be considered carefully when a preference has to be made for antibiotic prescribing.  The compelling importance of the fact that all healthcare personnel should take ownership of the need to specify accordingly and to practice effective infection control.  A realization that antibiotics may not be competent for the tasks required of them and eventually, with widespread resistance, may be incapable of the task they do today.

Relevant Conferences:

7th World Congress on Applied Microbiology, November 10-12, 2016 Istanbul, Turkey; Conference on Infectious Diseases and Diagnostic Microbiology, October 3-5, 2016 Vancouver, Canada; 6th Clinical Microbiology Conference, October 20-22, 2016 Rome, Italy; 2nd World Congress on Infectious Diseases, August 24-26, 2016 Philadelphia, Pennsylvania, USA; Meeting on Antimicrobial resistance in biofilms and options for treatment, October 05 - 07, 2016 Ghent, Belgium;3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, DC, USA; Keep Antibiotics Working (KAW), Institute for Agriculture and Trade Policy (IATP), Healthy Food Action, American Public Health Association, American Nurses Association, Natural Resources Defense Council (NRDC),

Track 6: Antibiotics for Various Diseases and Infections

Antibiotics are amidst the most regularly recommended medications in modern medicine. Antibiotics are useless against viral infections. When you take antibiotics, follow the guidelines carefully. It is important to finish your medicine even if you feel improved. If you stop treatment too soon, some bacteria may survive and re-infect you. Do not save antibiotics for later or use someone else's prescription.

Relevant Conferences:

2nd World Congress on Infectious Diseases, August 24-26, 2016 Philadelphia, Pennsylvania, USA; Conference on Infectious Diseases and Diagnostic Microbiology, October 3-5, 2016 Vancouver, Canada; Conference on Pediatric Care and Pediatric Infectious Disease, August 24-25, 2016 Philadelphia, Pennsylvania, USA; Conference on Rare Diseases and Orphan Drugs, Oct 26-27, 2016 Chicago, Illinois, USA; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, DC, USA; Conference in Antimicrobial Stewardship in Veterinary Medicine, September 10-11, 2016 Gothenburg, Sweden; Infectious Diseases Society of America (IDSA), U.S. Food and Drug Administration (FDA), Center for a Livable Future (CLF), The Pew Charitable Trusts, The Humane Society of the United States (HSUS), Food Animal Concern Trust (FACT),

Track 7: Antibiotic Prophylaxis

Antimicrobial prophylaxis is generally used by clinicians for the prevention of numerous infectious diseases. Optimal antimicrobial agents for prophylaxis should be nontoxic, inexpensive, bactericidal and active against the typical pathogens that can motive surgical site infection postoperatively. To maximize its effectiveness, intravenous perioperative prophylaxis should be carried out within 30 to 60 minutes before the surgical incision. Antimicrobial prophylaxis should be of short time to downturn toxicity and antimicrobial resistance and to reduce cost.

Relevant Conferences:

4th conference on Personalized Medicine and Molecular Diagnostics, September 22-24, 2016 Phoenix, USA; 2nd International Conference on Drug Discovery and Designing, November 08-09, 2016 Istanbul, Turkey; 4th Conference on Clinical Pharmacy, November 07-09, 2016 Las Vegas, Nevada, USA; Global Pharmaceutical Industry Summit, August 22-24, 2016 Vienna, Austria; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, DC, USA; Conference on Antimicrobial Stewardship in Veterinary Medicine, September 10-11, 2016 Gothenburg, Sweden; Antimicrobial Conference, September 8-9, 2016 Washington, USA; The Pew Charitable Trusts, The Humane Society of the United States (HSUS), Food Animal Concern Trust (FACT), Infectious Diseases Society of America (IDSA), U.S. Food and Drug Administration (FDA), Center for a Livable Future (CLF)

Track 8: Antibiotics: In Pregnancy and Lactation

Antibiotics are frequently recommended during pregnancy. The specific medication must be chosen carefully, however. Some antibiotics are prescribed to take during pregnancy, while others are not. Safety depends on various factors, including the type of antibiotic, when in pregnancy you take the antibiotic, how much you take and for how long. Antibiotics normally advised safe during pregnancy:  Ampicillin, Amoxicillin, Clindamycin, Erythromycin, Penicillin, Nitrofurantoin. Despite there's no direct clue that these antibiotics cause birth defects, additional research is needed. In the interim, use of these medications is still assured in some cases.

Relevant Conferences:

Conference on Reproductive Health, December 05-07, 2016 Dallas,  USA; 3rd Conference on Gynecology and Obstetrics, November 24-26, 2016 Dubai, UAE; 4th Conference on Clinical Pharmacy, November 07-09, 2016 Las Vegas, Nevada, USA; 5th Global Pharmacists Annual Meeting, July 14-16, 2016 Brisbane, Australia; EPHA 7th  Annual Conference on Antibiotic Resistance and Public Health, September 8, 2016 Brussels, Belgium; 4th Conference on the responsible use of Antibiotics in animals, September 26-28, 2016 The Hague, Netherlands; Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Compassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI), Center for Food Safety, Animal Welfare Approved (AWA), American Academy of Pediatrics, American Medical Association

Track 9: Antibiotics in Different Industries

Antibiotics must be used accordingly in humans and animals because both uses share to the emergence, persistence, and escalation of resistant bacteria. Resistant bacteria in food-producing animals are of particular concern. Food animals play as a source of resistant pathogens and resistance mechanisms that can directly or indirectly result in antibiotic resistant infections in humans. Resistant bacteria may be transmitted to humans through the foods we eat. Some bacteria have turned resistant to more than one sort of antibiotic, which makes it more difficult to treat the infections they cause. Sustaining the efficiency of antibiotic drugs is vital to insulating human and animal health.

Relevant Conferences:

5th Conference on Global Food Safety, December 05- 07, 2016 San Antonio, USA; 3rd Conference on Aquaculture and Fisheries, September 29-October 01, 2016 London, United Kingdom; Global Veterinary Microbiology Summit and Expo, October 17-19, 2016 Chicago Illinois, USA; 15th Conference on Food Processing and Technology, November 07-09, 2016 Istanbul, Turkey;  Conference on Antimicrobial resistance in biofilms and options for treatment, October 05 - 07, 2016 Ghent, Belgium;3rd Annual Microbiology and Infectious Diseases  Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, DC, USA;  Animal Welfare Approved (AWA), American Academy of Pediatrics, American Medical Association, Compassion in World Farming (CIWF), Center for Science in the Public Interest (CSPI), Center for Food Safety

Track 11: Drug Discovery and Novel Delivery Technologies

In the prior most drugs have been invented either by identifying the active ingredient from traditional remedies or by serendipitous discovery. A new access has been to recognize how disease and infection are controlled at the molecular and physiological level and to mark specific entities based on this knowledge. The process of drug discovery involves the identification of candidates, characterization, screening, synthesis, and assays for therapeutic efficacy. Evolution of an existing drug molecule from a ordinary form to a novel delivery system can significantly improve its performance in terms of patient compliance, efficacy and safety. These days, drug delivery companies are engaged in the development of numerous platform technologies to get ambitious advantage, extend patent life, and increase market share of their products. Formerly a compound has displayed its value in these tests; it will begin the process of drug development prior to clinical trials.

Relevant Conferences:

Drug Formulation Congress, September 05-07, 2016 Beijing, China; 2nd International Conference and Conference on Drug Discovery and Designing, November 08-09, 2016 Istanbul, Turkey; 10th Conference on Pharmaceutics and Novel Drug Delivery Systems, March 13-15, 2017 London, UK; 4th Conference on Clinical Pharmacy, November 07-09, 2016 Las Vegas, Nevada, USA; EPHA 7th Annual Conference on Antibiotic Resistance and Public Health, September 8, 2016 Brussels, Belgium; 4th conference on the responsible use of antibiotics in animals, September 26-28, 2016 The Hague, Netherlands; Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016; Centers for Disease Control and Prevention (CDC), Center for a Livable Future (CLF), U.S. Food and Drug Administration (FDA)

Track 12: Antibiotics for Emerging and Re-emerging Diseases

New diseases are originating globally and old diseases are re-emerging as Infectious agents evolve or spread, and as changes occur in conservation, socio-economic conditions, and population patterns. Likewise, many diseases thought to be decently controlled appear to be making a revival. In developed countries, public health measures such as sewage treatment, vaccination programs, sanitation and access to good medical care-including a wide range of antibiotics-have virtually disposed “traditional” diseases such as tuberculosis, diphtheria and whooping cough.

Relevant Conferences:

2nd World Congress on Infectious Diseases, August 25-27, 2016 Philadelphia, USA; Conference on Infectious Diseases and Diagnostic Microbiology, October 3-5, 2016 Vancouver, Canada; Conference on Pediatric Care and Pediatric Infectious Disease, August 24-25, 2016 Philadelphia, Pennsylvania, USA; Congress on Rare Diseases and Orphan Drugs, October 26-27, 2016 Chicago, Illinois, USA; Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium;3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, DC, USA; The World Alliance Against Antibiotic Resistance (WAAAR), Antibiotic Research UK (ANTRUK), Alliance for the Prudent Use of Antibiotics (APUA).

Track 13: Micro Organisms in Recent Drug Discovery

Environmental microbes are a leading source of drug discovery, and several microbial products ( anti-tumour products, antibiotics, immunosuppressants and others) are used frequently for human therapies. Most of these products were accessed from cultivable (<1%) environmental microbes, means that the large number of microbes were not targeted for drug discovery. With the onset of new and emerging technologies, we are poised to harvest novel drugs from the so-called 'uncultivable' microbes. Multidisciplinary way of linking different technologies can assist and reform drug discovery from uncultivable microbes and inspect the current cramp of technologies and scenario to swamped such constraints that might further expand the promise of drugs from environmental microbes.

Relevant Conferences:

5th Conference on Microbial Physiology and Genomics, September 29-30, 2016 London, UK; 6th Clinical Microbiology Conference October 20-22, 2016 Rome, Italy; Drug Formulation Meeting September 05-07, 2016 Beijing, China; 2nd Conference  on Drug Discovery and Designing, November 08-09, 2016 Istanbul, Turkey; Conference in Antimicrobial Stewardship in Veterinary Medicine, September 10-11, 2016 Gothenburg, Sweden; World Antimicrobial Congress, September 8-9, 2016 Washington, DC, USA; EPHA 7th Annual Conference on Antibiotic Resistance and Public Health, September 8, 2016 Brussels, Belgium; 4th conference on the responsible use of antibiotics in animals, September 26-28, 2016 The Hague, Netherlands; Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; Global Antibiotic Resistance Partnership (GARP), British Pharmacological Society (BPS), American Society for Microbiology (ASM)

Track 14: Clinical Trials of Antibiotics

Prescribing doctors are, progressively, using clinical trial data as a major source of information for evidence-based medicine for the remedy of infectious diseases, as in other clinical disciplines. However, it may be difficult to excerpt from these data the material that is needed for the management of the individual patient. At the same time, clinical trial testimony have been used, probably satisfactorily, in the process of drug registration, and the pharmaceutical industry has spent progressively large amount of money to satisfy the needs of this process. In the face of all these problems, switch in the way antibiotic clinical trials are designed and performed are clearly necessary, although this must not disturb the balance so far as to restore them less useful for those who currently derive greatest benefit from them.

Relevant Conferences:

2nd Conference on Clinical Trials, August 22-24, 2016 Philadelphia, USA; 4th Conference on Clinical Pharmacy, November 07-09, 2016 Las Vegas, Nevada, USA; 6th Clinical Microbiology Conference, October 20-22, 2016 Rome, Italy; 2nd Conference on Therapeutic Drug Monitoring and Toxicogenomics, August 25-26, 2016 Philadelphia, Pennsylvania, USA; 3rd World Congress on Pharmacology, August 08-10, 2016 Birmingham, UK; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, USA; Conference on Antimicrobial Stewardship in Veterinary Medicine, September 10-11, 2016 Gothenburg, Sweden; Infectious Diseases Society of America (IDSA), U.S. Food and Drug Administration (FDA), Center for a Livable Future (CLF)

Track 15: Antibiotics and Mechanism of Action

Antibacterial action customarily falls within one of four mechanisms, three of which involve the inhibition or regulation of enzymes tangled in cell wall biosynthesis, nucleic acid metabolism and repair, or protein synthesis, respectively. The fourth mechanism associates the interruption of membrane structure. Many of these cellular functions targeted by antibiotics are most effective in multiplying cells. Since there is often overlap in these functions between eukaryotic mammalian cells and prokaryotic bacterial cells, it is not surprising that some antibiotics have also been found to be useful as anticancer agents.

Relevant Conferences:

Conference on Drug Formulation, September 05-07, 2016 Beijing, China; 2nd International Conference and Conference on Drug Discovery and Designing, November 08-09, 2016 Istanbul, Turkey; 10th International Conference on Pharmaceutics and Novel Drug Delivery Systems, March 13-15, 2017 London, UK; 4th Conference on Clinical Pharmacy, November 07-09, 2016 Las Vegas, Nevada, USA; EPHA 7th  Annual Conference on Antibiotic Resistance and Public Health, September 8, 2016 Brussels, Belgium; 4th conference on the responsible use of antibiotics in animals, September 26-28, 2016 The Hague, Netherlands; Conference on Antimicrobial resistance in biofilms and options for treatment, October 05-07, 2016 Ghent, Belgium; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Keep Antibiotics Working (KAW), Institute for Agriculture and Trade Policy (IATP), Healthy Food Action

Track 16: Antibiotic Regulatory Affairs

 Regulatory affairs (RA), are also called as government affairs, is a profession within regulated industries, such as medical devices, pharmaceuticals etc. Regulatory affairs also have a very specific meaning within the healthcare industries (medical devices, functional foods, biologics and pharmaceuticals). Regulatory affairs (medical affairs) professionals (aka regulatory professionals) generally have the duty for the following general areas: Ensuring that the companies obey with all of the regulations and laws pertaining to their business.

Relevant Conferences:

 6th Conference on Pharmaceutical Regulatory Affairs and IPR, September 29-October 01, 2016 Orlando, USA; Conference on Drug Formulation, September 05-07, 2016 Beijing, China; 2nd Conference on Drug Discovery and Designing, November 08-09, 2016 Istanbul, Turkey; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, DC, USA; Conference on Antimicrobial Stewardship in Veterinary Medicine, September 10-11, 2016 Gothenburg, Sweden; World Antimicrobial Congress, September 8-9, 2016 Washington, DC, USA; Animal Welfare Approved (AWA), American Academy of Pediatrics, American Medical Association

Track 17: Antibiotics: Market Analysis and Business Opportunities

The global antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. From, 2005 this market is seen to grow at an annual rate of 6.6% until 2011. There are many companies producing antibiotics these days and there are many other antibiotics present in the market such as aminoglycoside antibiotics and it cap around 79% of the global demand. Moreover, the other antibiotics such as penicillin have 8%, streptomycin  1%, chloramnphenicol 1 % , tetracyclines 4%, erythromycin has 7%, market.

Relevant Conferences:

Conference on Pharma Marketing, November 10-11, 2016 Alicante, Spain; Conference on Generic Drug Market and Contract Manufacturing, November 07-09, 2016 Barcelona, Spain; 2nd Conference on Drug Discovery and Designing, November 08-09, 2016 Istanbul, Turkey; Global Pharmaceutical Industry Summit, August 22-24, 2016, Vienna, Austria; 3rd Annual Microbiology and Infectious Diseases Congress, October 11-12, 2016 Singapore; Conference on Developing Antibiotic Alternatives: A Discussion Of New Approaches To Overcoming Antimicrobial Resistance, November 8-11, 2016;  Conference On Contemporary Antimicrobial Research,  November 14-17, 2016 Silchar, India; ASM Conference on Antibacterial Development, December 11-14, 2016 Washington, DC, USA; Conference on Antimicrobial Stewardship in Veterinary Medicine, September 10-11, 2016 Gothenburg, Sweden; Infectious Diseases Society of America (IDSA), U.S. Food and Drug Administration (FDA), Center for a Livable Future (CLF).

Conference Series LLC is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. After a successful conference of Antibiotics 2015, Conference Series LLC is currently bringing forth "2nd World Congress and Exhibition on Antibiotics and Antibiotic Resistance" (Antibiotics 2016) slated on October 13-15, 2016 at Manchester, UK.

This is our consecutive conference and expo with reference to the overwhelming success of our previous conferences in Pharma, Therapeutics, Drug Manufacturers, Business Management and Marketing.

Conference Series LLC through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. Conference Series LLC hosts over 700 leading-edge peer  reviewed Open Access Journals and has organized over 1000 Scientific Conferences all over the world. Conference Series LLC journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 50000 eminent personalities and the rapid, quality and quick review processing. Conference Series LLC Conference is a great platform for the researchers to understand the need of new Antibiotics and the threat going to face by antibiotic resistance. Target Audience for Antibiotics 2016 includes Researchers, Industrialists, Students and Public Sector Experts.

Why to attend??

With members from around the world focused on learning about Antibiotics and its advances; this is your best opportunity to reach the largest assemblage of participants from the Antibiotics community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Antibiotics are hallmarks of this conference.

You will meet!

  •  Food Safety Experts
  • Alliances of antibiotics
  • Public Health Preparedness Sectors
  • Commercialization
  • Strategic Drug Development
  • Scientific Business Communications
  • Medical Affairs and Networking
  • Executive Council of Global 
  • Directors of Pharma Industries
  • Antibiotics Associations & Societies
  • Business Entrepreneurs
  • Antibiotics Researchers

Summary

Antibiotics 2016 welcomes attendees, presenters, and exhibitors from all over the world to Manchester, UK. We are delighted to invite you all to attend and register for the “2nd World Congress & Exhibition on Antibiotics and Antibiotic Resistance” (Antibiotics 2016) which is going to be held during October 13-15, 2016 at Manchester, UK. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Antibiotics 2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Antibiotics 2016 organizing committee look forward to meet you at Manchester, UK

Importance and Scope:

Antibiotics play a crucial role in the health of both human beings and animals. The purpose of the Antibiotic research is to stimulate discussion of new ideas and/or find new perspectives on the future of Antibiotics as there are no major Antibiotics had been discovered during the past few years. Moreover Antimicrobial resistance threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. It is an increasingly serious threat to global public health that requires action across all government sectors and society. Antimicrobial resistance is present in all parts of the world. New resistance mechanisms emerge and spread globally. Infections caused by resistant microorganisms often fail to respond to the standard treatment, resulting in prolonged illness, higher health care expenditures, and a greater risk of death.

SCOPE OF REPORT This research report categorizes the systemic antibiotics market into the following segments:

Antibiotics market (human application) by product:

  • Beta-lactams: Penicillin. Cephalosporins. Carbapenems.

  • Fluoroquinolones: Second generation. Third generation. Others.

  • Macrolides.

  • Tetracycline.

  • Other antibiotic classes

 Antibiotics market by application:

  • Human applications.

  • Veterinary applications

Therefore it is necessary to focus on new Antibiotics and the solutions to reduce Antibiotic resistance.

Why Manchester?

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. Analyses of global market trends, with data from 2013, and projections of compound annual growth rates (CAGRs) through 2018. The United Kingdom is one of the world’s largest markets for pharmaceuticals.  Manchester itself contains around 40 pharmaceutical companies. Manchester is the perfect place to indulge a love of culture. The leading players in the global antibiotics market include Pfizer Inc. (U.S.), Merck and Co. (U.S.), Eli Lilly and Co. (U.S.), Sanofi-Aventis (France), AstraZeneca (U.K.), Cubist pharmaceuticals (U.S.), Johnson & Johnson (U.S.) and GlaxoSmithKline PLC (U.K.). Don’t miss the year-round programs of special exhibitions of art, photography and design at The Lowry or catch a play or musical. And at the magnificent Royal Exchange Theatre you’ll find live music events, free exhibitions, poetry readings as well as top-class theatre

Conference Highlights:

  • Antibiotics

  • The Emergence of Antimicrobial resistance

  • Antibiotic Resistance: Opportunities and Challenges

  • Different Types of Antibiotics

  • Applications of Antibiotics

  • Antibiotics for Various Diseases and Infections

  • Antibiotic Prophylaxis

  • Antibiotics: In Pregnancy and Lactation

  • Antibiotics in Different Industries

  • Modern Antibiotics

  • Drug Discovery and Novel Delivery Technologies

  • Antibiotics for Emerging and Re-emerging Diseases

  • Micro Organisms in Recent Drug Discovery

  • Clinical Trials of Antibiotics

  • Antibiotics and Mechanism

  • Antibiotic Regulatory Affairs

  • Antibiotics: Market Analysis & Business Opportunities

Organizations working on Antibiotics around the Globe:

  • Infectious Diseases Society of America

  • World Health Organization

  • U.S. Food and Drug Administration (FDA)

  • Center for a Livable Future (CLF)

  • Centers for Disease Control and Prevention (CDC)

  • American Medical Association

  • American Academy of Pediatrics

  • Animal Welfare Approved (AWA)

  • Center for Food Safety

  • Center for Science in the Public Interest (CSPI)

  • Compassion in World Farming (CIWF)

  • Consumers Union

  • Fix Food

  • Food Animal Concern Trust (FACT)

  • Soil Association

  • Sustain

  • The Humane Society of the United States (HSUS)

  • The Pew Charitable Trusts

  • Food and Water Watch

  • Healthy Food Action

  • Institute for Agriculture and Trade Policy (IATP)

  • Keep Antibiotics Working (KAW)

  • Natural Resources Defense Council (NRDC)

  • American Nurses Association

  • American Public Health Association

  • Institute of Medicine, National Academies of Science

  • American Society for Microbiology

Societies working on Antibiotics in UK:

  • The World Alliance Against Antibiotic Resistance (Waaar)

  • BEAM Alliance (Biotechs from Europe innovating in anti-microbial resistance)

  • Antibiotic Research UK (ANTRUK)

  • Alliance for the Prudent Use of Antibiotics (APUA)

  • ReAct – Action on Antibiotics

  • Transatlantic task force on urgent antimicrobial resistance –(TATFAR)

  • Global Antibiotic Resistance Partnership (GARP)

  • British Pharmacological Society (BPS)

Top Universities in UK:

  • University of Cambridge

  • University of Oxford

  • Imperial College London

  • Durham University

  • St Andrews

  • University of Warwick

  • University of Surrey

  • Lancaster University

  • University of Exeter

  • University of Bath

  • Loughborough University

  • University College London

  • University of Southampton

  • University of Bristol

  • University of East Anglia

  • University of York

  • University of Birmingham

 

Top Hospitals in UK:

  • BMI Healthcare Center: Manchester

  • London Fertility Center: London

  • Louth County Hospital: Lincolnshire

  • London Road Community Hospital: Derby

  • John Coupland Hospital: Lincolnshire

  • NHS Tayside: London

  • National Hospital for Neurology: London

  • Rampton Secure Hospital: Nottinghamshire

  • Cancer Royal Hospital: London

  • Royal National Orthopedic Hospital: western London

Major Hospitals in Manchester:

  • Spire Manchester Hospital

  • Christie Hospital

  • Central Manchester & Manchester Children's Hospital

  • Stretford Memorial Hospital

  • Care UK

  • Withington Community Hospital

  • Royal Manchester Children's Hospital

  • North Manchester General Hospital

  • Wythenshawe Hospital

  • University Hospital of South Manchester

  • Salford Royal - University of Manchester

 

Antibiotics: Global Markets Analysis

 

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%. The global market for antifungal therapeutics was valued at $10.7 billion in 2013 and is projected to reach $12.2 billion in 2018, a five-year compound annual growth rate (CAGR) of 2.7%.

 

Overall sales in the current antibiotics and new products market were nearly $40 billion in 2008. It increased to $41.5 billion in 2009. By 2015, it is projected to increase to $65.5 billion, for a 5-year compound annual growth rate (CAGR) of 9.6%. The largest segment antibiotic drugs market was nearly $36 billion in 2008; this further increased to $37 billion in 2009, this projected to reach $50 billion in 2015, for a 5-year CAGR of 5.9%. Sales in the bacterial vaccines market amounted to $3.6 billion in 2008 which increased slightly to $3.9 billion in 2009. This is projected to increase to $15 billion in 2015, for a 5-year CAGR of 31.6%.

 

Funding for research:

From a total research fund of £13,846.1 million allotted to the UK agencies, £269.2 million (1.9%) was awarded to bacteriology projects and £95.0 million (0.7%) to antibiotics research. An additional £181.4 million was awarded to antibiotic research by the European Union, of which £85.2 million came from 2 Innovative Medicines Initiative awards.

Antibiotics-2015

A huge success has been achieved by OMICS International in hosting “World Congress & Exhibition on Antibiotics” scheduled during September 14-16, 2015 Las Vegas, USA with the theme “The Urgency of New Antibiotics and Control of Antibiotic Resistance”.

The annual conference brought together many eminent scientists from across 20 countries in which many critical issues were discussed in depth to provide up-to-date information to the World. On the other hand, the meeting provided a rostrum for domestic researchers to communicate with international experts which resulted in great exchange of knowledge. We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Antibiotics-2015 a grandiose event.

The meeting was carried out through various sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

  • The Vast Area of Antibiotics & Antibiotic Prophylaxis

  • Antibiotic Resistance: Opportunities and Challenges

  • Microorganisms in Recent Drug Discovery

  • Responsible use of Antibiotics

  • Optimization of Therapy-General principles

  • Antibiotics in Prevention and Treatment of Inflammatory and Infectious Diseases

  • Antibiotics: Water Born Diseases

  • Antibiotics and Allergies: Clinical Update

  • Antibiotics: Agriculture, Veterinary and Aquaculture

  • Antibiotics in Child care, Dental and Oral care

  • Antibiotics for Emerging and Re-emerging Diseases

  • Modern Antibiotics: Emerging Trends, Barriers and Opportunities

  • Antibiotics: Market Analysis & Business Opportunities

  • Antibiotic Regulatory Affairs

  • Antibiotics and Mechanism

  • Drug Discovery 

The conference was embarked with an opening ceremony followed by workshop and a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

  • Jeffrey H Miller, University of California, USA

  • John J S Cadwell, Fiber Cell Systems Inc., USA

  • Glenn S Tillotson, TranScrip Partners, USA

  • Martin Duerden, Bangor University, UK

Symposia include professional presentation by Glenn S Tillotson, TranScrip Partners, USA on “Clostridium difficile”.

Exclusive session includes presentation by John M Clerici, Tiber Creek Partners, USA on “Development and procurement of biotechnology for emerging disease and engineered threats in the public health preparedness sector”.

OMICS International thanks all the expert presenters across the globe which includes various experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Antibiotics 2015, OMICS International is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, “2nd World Congress and Exhibition on Antibiotics and Antibiotic Resistance’’ which is scheduled to organize on October 13-15, 2016 Manchester, UK.

Let us meet again @ Antibiotics 2016


Past Reports  Gallery  

Bacteriology-2014

2nd International Congress on Bacteriology and Infectious Diseases (Bacteriology-2014)was held during November 17-19, 2014 at Doubletree by Hilton Hotel Chicago-North Shore, USA. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Current concepts and diagnosis in bacteriology” 

Bacteriology-2014 is moderated by Dr. Gregory A. Buck from Virginia Commonwealth University, USA

We are thankful to our below Honourable guests and Keynote Speakers for their generous support and suggestions.

  • Michael Y. Galperin– National Center for Biotechnology Information, USA

  • Ed T Buurman - AstraZeneca, USA

  • Massimo Cecaro - EIC, National Councilor of Italian Medical Press, Italy

  • Stephen Hanessian - University of Montreal, Canada

  • Marcelo E. Tolmasky - California State University Fullerton, USA

  • Akira Kaji - University of Pennsylvania, USA

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

  • Diversity of the Human Vaginal Microbiome:  Gregory A. Buck, Virginia Commonwealth University, USA

  • Functional annotation of bacterial genomes one COG at a time: Michael Y. Galperin– National Center for Biotechnology Information, USA

  • Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome: Ed T Buurman - AstraZeneca, USA

  • Emerging infectious diseases: Anthropozoonoses and global change: Massimo Cecaro - EIC, National Councilor of Italian Medical Press, Italy

  • RNA binding molecules: Structure, function and synthesis: Stephen Hanessian - University of Montreal, Canada

  • Multidrug resistant bacterial pathogens: the need for action: Marcelo E. Tolmasky - California State University Fullerton, USA

  • Ribosome recycling in prokaryotes and eukaryotes: Akira Kaji - University of Pennsylvania, USA

  • Various sessions were chaired and co chaired by: Phillip E. Klebba, Kansas State University, USA,    Abu Salim Mustafa, Kuwait University, Kuwait; Kei Amemiya, US Army Medical Research Institute of Infectious Diseases, USA, Joyce A. Sutcliffe,Tetraphase Pharmaceuticals, USA; Thea Sesardic, National Institute for Biological Standards and Control, UK, Kwang Poo Chang, Rosalind Franklin University of Medicine and Science, USA; Eric T. Harvill, Penn State University, USA, Wanda C. Reygaert, Oakland University, USA

  • Poster Session was judged by Michael Y. Galperin– National Center for Biotechnology Information, USA  and Ilaria Ferlenghi, Novartis Vaccines Research Centre, Italy

OMICS Group has taken the privilege of felicitating Bacteriology-2014 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Bacteriology-2014. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Bacteriology and Parasitology as a special issue.


Past Reports  Gallery  

Bacteriology-2013

International Congress on Bacteriology and Infectious Diseases  (Bacteriology-2013)was held during November 20-22, 2013 at DoubleTree by Hilton Baltimore-BWI Airport , Baltimore, USA.. The conference was marked with the attendance of Editorial Board Members of supported OMICS Group Journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Current concepts and diagnosis in bacteriology”

Bacteriology-2013 was moderated by Dr. Fernando Villalta,

(Chair and Professor of Immunology, School of Medicine, Meharry Medical College, USA)

We are thankful to our below Honourable guests and Keynote Speakers for their generous support and suggestions.

  • Gregory A. Buck- Virginia Commonwealth University, USA

  • Jean Pierre Changeux– Pasteur Institute, France

  • Dennis J. Helfritch- U.S. Army Research Laboratory, USA

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

  • Extensive richness of the human vaginal microbiome:  Gregory A. Buck, USA

  • From Bacteria to Brain: Structure and Pharmacology of Neurotransmitter

  • Receptor Channels: Jean Pierre Changeux, Pasteur Institute, France

  • The antimicrobial effectiveness of spray deposited copper surfaces: Dennis J. Helfritch, U.S. Army Research Laboratory, USA

  • Various sessions were chaired and co chaired by: Menachem Shoham, Case Western Reserve University, USA, Richard G. Brennan, Duke University School of Medicine, USA, Jean Pierre Changeux, Pasteur Institute, France, Antonio Molinaro, European Carbohydrate Organization, Italy, John G Thomas, West Virginia University, USA, Steven D. Goodman, Nationwide Children's Hospital, USA, Jay H. Bream, Johns Hopkins Bloomberg School of Public Health, USA, Jacques H. Grosset, Johns Hopkins University School of Medicine, USA, Ayman M. Noreddin, Hampton University, USA.

OMICS Group has taken the privilege of felicitating Bacteriology-2013 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.


The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Bacteriology-2013. We are glad to inform that all accepted abstracts for the conference have been published in OMICS Group Journal of Bacteriology and Parasitology as a special issue.


Past Reports  Gallery  

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 13-15, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Conferenceseries Destinations